777 SAFETY, TOLERABILITYAND PHARMACOKINETIC OF MULTIPLE ASCENDING DOSES OF THE EP-1 RECEPTOR ANTAGONIST ONO-8539, A POTENTIAL NEW AND NOVEL THERAPY TO OVERACTIVE BLADDER IN HEALTHY YOUNG AND ELDERLY SUBJECTSDarren Wilbraham, Séverine Vincent, Takahiro Masuda et al.|European Urology Supplements|2010Cited by 5
783 URINARY PROSTAGLANDIN E2 LEVELS ARE ELEVATED IN PATIENTS WITH OVERACTIVE BLADDER AND PAINFUL BLADDER SYNDROME AND CORRELATE WITH BLADDER DIARY SYMPTOMSPaul Abrams, Steve Deacon, G. Amarenco et al.|European Urology Supplements|2010Cited by 1